Home › HARDY DIAGNOSTICS › N/A
N/A
HARDY DIAGNOSTICS · Model A150 · UDI-DI 00816576023899
10
510(k) clearances
538
Adverse events
6
Recalls
24
Facilities
Description
StrePlate™, 15x100mm Monoplate, 22ml. Hardy Diagnostics' Bacti-Lab StrePlate™ is on enriched media for the selective isolation of all Streptococcus spp., including beta-hemolytic group A (Streptococcus pyogenes), group B (Streptococcus agalactiae), groups C, D, F and G; and Streptococcus pneumoniae.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-02-05 | Remel, Inc | Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. |
| 2018-08-02 | Acumedia Manufacturers, Inc. | The product is labeled with an incorrect expiration date. |
| 2016-03-21 | Hardy Diagnostics | Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to produc |
| 2013-06-06 | Becton Dickinson & Co. | Microbiological identification media may exhibit reduced levels of Vancomycin. |
| 2013-06-06 | Becton Dickinson & Co. | Microbiological identification media may exhibit reduced levels of Vancomycin. |
| 2013-06-06 | Becton Dickinson & Co. | Microbiological identification media may exhibit reduced levels of Vancomycin. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.